Tanespimycin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tanespimycin" in English language version.

refsWebsite

Global rank English rank

2clinicaltrials.gov

5,225^th place

4,062^nd place

2^nd place

2^nd place

4^th place

4^th place

1web.archive.org

1^st place

1^st place

1myelomabeacon.com

low place

low place

clinicaltrials.gov (Global: 5,225^th place; English: 4,062^nd place)

Clinical trial number NCT00093821 for "Phase 1 trial: 17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors" at ClinicalTrials.gov
Clinical trial number NCT00079404 for "Phase 1 trial: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia" at ClinicalTrials.gov

doi.org (Global: 2^nd place; English: 2^nd place)

Dimopoulos MA, Mitsiades CS, Anderson KC, Richardson PG (February 2011). "Tanespimycin as antitumor therapy". Clinical Lymphoma, Myeloma & Leukemia. 11 (1): 17–22. doi:10.3816/CLML.2011.n.002. PMID 21454186.

myelomabeacon.com (Global: low place; English: low place)

"Bristol-Myers Squibb Halts Development of Tanespimycin". The Myeloma Beacon. 22 July 2010. Archived from the original on 28 December 2010.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Dimopoulos MA, Mitsiades CS, Anderson KC, Richardson PG (February 2011). "Tanespimycin as antitumor therapy". Clinical Lymphoma, Myeloma & Leukemia. 11 (1): 17–22. doi:10.3816/CLML.2011.n.002. PMID 21454186.

web.archive.org (Global: 1^st place; English: 1^st place)

"Bristol-Myers Squibb Halts Development of Tanespimycin". The Myeloma Beacon. 22 July 2010. Archived from the original on 28 December 2010.